MYTEKA 4 mg (Montelukast Sodium) 14’S is an oral leukotriene receptor antagonist designed to manage and prevent symptoms associated with asthma and allergic rhinitis. Each tablet contains 4 mg of Montelukast Sodium, a medication that works by blocking leukotrienes—chemicals in the body that cause inflammation, bronchoconstriction, and mucus production. MYTEKA is commonly prescribed for individuals with persistent asthma and seasonal or perennial allergic rhinitis, providing effective relief from symptoms such as wheezing, shortness of breath, nasal congestion, and sneezing. Its convenient tablet form ensures easy administration, enhancing patient adherence and overall respiratory health.
Key Features and Benefits:
- Effective Leukotriene Inhibition: Montelukast Sodium blocks leukotriene receptors, reducing inflammation, bronchoconstriction, and mucus production in the airways.
- Asthma Management: Helps prevent and control asthma symptoms, including wheezing, shortness of breath, and chest tightness, thereby improving lung function and overall respiratory health.
- Allergic Rhinitis Relief: Alleviates symptoms of seasonal and perennial allergic rhinitis, such as nasal congestion, sneezing, runny nose, and itchy eyes, enhancing daily comfort and productivity.
- Once-Daily Dosing: Offers the convenience of once-daily administration, promoting better adherence to treatment regimens and simplifying medication schedules.
- Non-Sedating: Unlike some antihistamines, Montelukast does not typically cause drowsiness, allowing individuals to maintain their daily activities without impairment.
- Preventive Therapy: Acts as a preventive medication, reducing the frequency and severity of asthma attacks and allergic reactions when taken regularly as prescribed.
- Proven Efficacy: Backed by extensive clinical research, MYTEKA has demonstrated its effectiveness in managing chronic respiratory conditions, making it a trusted choice for healthcare providers and patients alike.
- Convenient Packaging: Available in blister packs containing 14 tablets, ensuring an adequate supply for consistent and prolonged treatment as directed by a healthcare professional.
Usage Instructions:
- Dosage:
- Adults and Adolescents (15 years and older): Take 1 tablet (4 mg) once daily in the evening.
- Children (6 to 14 years): Take 1 tablet (4 mg) once daily in the evening.
- Children (2 to 5 years): Consult a pediatrician for appropriate dosing, as formulations for this age group may vary.
- Administration:
- Take MYTEKA tablets orally with or without food.
- Swallow the tablet whole with a sufficient amount of water. Do not crush or chew the tablet.
- Frequency:
- Administer MYTEKA 4 mg once daily, preferably in the evening, to maximize its preventive effects on nighttime asthma symptoms and overall respiratory health.
- Duration of Treatment:
- Continue taking MYTEKA as prescribed by your healthcare provider, even if you feel well, to ensure continuous management of asthma and allergic rhinitis symptoms.
- Do not discontinue use without consulting your healthcare provider, as sudden cessation may lead to a resurgence of symptoms.
- Missed Dose:
- If you miss a dose, take it as soon as you remember.
- If it is near the time of your next dose, skip the missed dose and resume your regular dosing schedule.
- Do not take two doses at the same time to make up for a missed dose.
Precautions:
- Consult a Healthcare Provider: Always use MYTEKA 4 mg under the supervision of a qualified healthcare professional to ensure it is appropriate for your specific health condition and to determine the correct dosage.
- Allergic Reactions: Discontinue use and seek immediate medical attention if you experience signs of an allergic reaction, such as rash, itching, swelling, severe dizziness, or difficulty breathing.
- Mental Health Considerations: Montelukast has been associated with mood changes and suicidal thoughts in some individuals. Monitor for any changes in mood or behavior and report them to your healthcare provider immediately.
- Liver Function: Inform your healthcare provider if you have a history of liver disease, as Montelukast is metabolized in the liver and may require dosage adjustments.
- Pregnancy and Breastfeeding: Consult your healthcare provider before using MYTEKA if you are pregnant, planning to become pregnant, or breastfeeding, as the medication may affect fetal development or pass into breast milk.
- Drug Interactions: Inform your healthcare provider about all other medications and supplements you are taking, as Montelukast may interact with other drugs that affect the central nervous system or respiratory system.
- Avoid Smoking: Smoking may exacerbate asthma symptoms and reduce the effectiveness of MYTEKA. Consider quitting smoking to enhance treatment outcomes.
Possible Side Effects:
- Common Side Effects:
- Headache
- Dizziness
- Nausea
- Diarrhea
- Fatigue
- Upper respiratory tract infections
- Less Common Side Effects:
- Cough
- Sore throat
- Muscle pain
- Joint pain
- Serious Side Effects (Seek Medical Attention Immediately):
- Signs of severe allergic reaction, including hives, difficulty breathing, or swelling of the face, lips, tongue, or throat
- Mood changes, such as agitation, depression, or suicidal thoughts
- Seizures
- Severe abdominal pain
- Persistent vomiting
Storage Instructions:
- Temperature: Store MYTEKA 4 mg tablets at room temperature, between 15°C to 30°C (59°F to 86°F), away from direct sunlight and moisture to maintain their efficacy.
- Accessibility: Keep the medication out of reach of children to prevent accidental ingestion.
- Packaging Integrity: Ensure that the blister pack is tightly sealed after each use to protect the tablets from environmental factors and maintain their shelf life.
- Expiration: Do not use the tablets beyond the expiration date indicated on the packaging. Discard any unused medication after this date.
- Proper Handling: Avoid contaminating the tablets by ensuring that hands are clean before handling and that the tablets are not exposed to moisture or other contaminants.